Article Listing - PRESIDENT OF RHONE-POULENC RORER JAPAN

INTERFERON ALFA-N3 AND AIDS

6 April 1992

Researchers at the Walter Reed Army Institute of Research and at Interferon Sciences have commenced Phase I trials with the...

GERMAN POLICY UNDER FIRE

6 April 1992

German Health Minister Gerda Hasselfeldt has accused the leading German doctors' organization, the Hartmannbund, of political agitation, after it held...

WALDEGRAVE GIVES MESSAGE TO UK PHARMA INDUSTY

6 April 1992

From UK Health Secretary William Waldegrave

As the UK's general election campaigning draws to a conclusion, Secretary of State for Health...

BIOSCIENCE/FUTURE MEDICAL DEAL

6 April 1992

Bioscience International has reached an agreement with Future Medical Products to begin testing of a product used to neutralize HIV....

DURAMED'S ISONIAZID

6 April 1992

The resurgence of tuberculosis brought about by the AIDS epidemic has caused generic drugs company Duramed Pharmaceut-icals to resume manufacture...

GENZYME AND CYSTIC FIBROSIS

6 April 1992

Genzyme is to exercise its option to buy rights to Neozyme's cystic fibrosis protein replacement therapeutic program, under the terms...

BLOOD BANKING AND PLASMA PRODUCTS

6 April 1992

The world market for blood banking and plasma products was valued at $2.5 billion in 1990, and is expected to...

GLAXO FRANCE CHIEF QUITS

6 April 1992

Edwin Nathan, president of Glaxo France and of the group's Belgian and Luxembourg companies, has announced his departure from the...

ARAB PHARMA COOPERATION

6 April 1992

The executive board of the Union of Arab Druggists, meeting in Cairo, has established a new system of cooperation in...

GLOBAL MARKETS AND FACTORS FOR SUCCESS

6 April 1992

As the geographical borders between pharmaceutical markets begin to disappear, so do the differences among the critical success factors for...